Healthcare ServicesCompany
Boehringer Ingelheim M&A Summary
Boehringer Ingelheim has acquired 13 companies, including 11 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 3 assets.
Boehringer Ingelheim’s largest acquisition to date was in 2020, when it acquired NBE-Therapeutics AG for $1.3B. It’s largest disclosed sale occurred in 2016, when it sold Boehringer Ingelheim - Interferon Gamma-1b to Horizon Therapeutics Public Limited Company for $28M. Boehringer Ingelheim has acquired in 3 different US states, and 7 countries. The Company’s most targeted sectors include life science (85%) and consumer services (8%).
Boehringer Ingelheim Business Overview
Where is Boehringer Ingelheim headquartered?
Boehringer Ingelheim is headquartered in Ingelheim am Rhein, Germany.
What sector is Boehringer Ingelheim in?
Boehringer Ingelheim is a healthcare services company.
M&A Summary
-
M&A Total Activity16
- M&A Buy Activity13
- M&A Sell Activity3
- Total Sectors Invested 3
- Total Countries Invested 7
- M&A Buy/Sell Connections 5
Unlimited Searches
